The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase I study of enfortumab vedotin (ASG-22CE; ASG-22ME): Updated analysis of patients with metastatic urothelial cancer.
 
Daniel Peter Petrylak
Stock and Other Ownership Interests - Bellicum Pharmaceuticals; TYME
Honoraria - Astellas Pharma; Bayer; Bellicum Pharmaceuticals; Exelixis; Ferring; Genentech; Johnson & Johnson; Medivation; Merck Serono; Millennium; Pfizer; Progenics; Sanofi
Consulting or Advisory Role - Bayer; Bellicum Pharmaceuticals; Dendreon; Exelixis; Ferring; Johnson & Johnson; Medivation; Millennium; Pfizer; Sanofi
Research Funding - Astellas Medivation; Dendreon; Endocyte; Genentech; gtx; Johnson & Johnson; Merck; Millennium; Novartis; Oncogenex; Progenics; progenics; Sanofi
Expert Testimony - Celgene; sanofi
Travel, Accommodations, Expenses - Bayer; Bellicum Pharmaceuticals; Celgene; Dendreon; Exelixis; Ferring; Johnson & Johnson; Medivation; Millennium; Oncogenex; Pfizer; Progenics; Sanofi
 
Raymond P. Perez
Consulting or Advisory Role - Pharmaceutical Research Associates
Research Funding - Agensys (Inst); Altor BioScience (Inst); Bristol-Myers Squibb (Inst); Dompé Farmaceutici (Inst); Genentech/Roche (Inst); Immunogen (Inst); Incyte (Inst); Lilly (Inst); MedImmune (Inst); Millennium (Inst); Novartis (Inst); Onyx (Inst); Regeneron (Inst); TetraLogic Pharmaceuticals (Inst)
 
Jingsong Zhang
Honoraria - AstraZeneca; Bayer; Sanofi
Consulting or Advisory Role - Bayer; Sanofi
Speakers' Bureau - AstraZeneca; Sanofi
Research Funding - Astellas Pharma; Bayer
 
David C. Smith
Research Funding - Agensys (Inst); Atterocor (Inst); Bayer (Inst); Boston Biomedical (Inst); Bristol-Myers Squibb/Medarex (Inst); Celgene (Inst); ESSA (Inst); Exelixis (Inst); Genentech (Inst); ImClone Systems (Inst); Incyte (Inst); Lilly (Inst); MedImmune (Inst); Medivation/Astellas (Inst); Millennium (Inst); Novartis (Inst); Oncogenex (Inst); OncoMed (Inst); Regeneron (Inst); Seagen (Inst); Takeda (Inst); Tekmira (Inst); Teva (Inst)
 
Joseph D. Ruether
Speakers' Bureau - Astellas Pharma; Novartis
Research Funding - Astellas Pharma
 
Srikala S. Sridhar
Consulting or Advisory Role - Astellas Pharma; AstraZeneca (Inst); Janssen (Inst); Merck (Inst); Pfizer (Inst); Roche (Inst)
 
Randeep S. Sangha
Honoraria - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Lilly; Lundbeck; Merck; Pfizer; Roche
Research Funding - Abbvie (Inst); Agensys (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Janssen (Inst); Novartis (Inst); Roche (Inst)
 
Joshua Michael Lang
Stock and Other Ownership Interests - Salus Discovery
Consulting or Advisory Role - Sanofi; Sanofi
Research Funding - Agensys (Inst); Medivation (Inst); Novartis (Inst)
Patents, Royalties, Other Intellectual Property - I am listed on the patent on a technology for rare cell capture and analysis. This technology has been licensed by Salus Discovery, LLC though no commercial products are available.
 
Elisabeth I. Heath
Honoraria - Bayer; Dendreon; Sanofi
Consulting or Advisory Role - Agensys
Speakers' Bureau - Sanofi
Research Funding - Agensys (Inst); Celgene (Inst); Celldex (Inst); Dendreon (Inst); Genentech/Roche (Inst); Inovio Pharmaceuticals (Inst); Millennium (Inst); Seagen (Inst); Tokai Pharmaceuticals (Inst)
 
Jaime R. Merchan
Consulting or Advisory Role - Exelixis
Research Funding - Agensys; Lilly; Novartis; Rexahn Pharmaceuticals; Tocagen; TRACON Pharma
 
Elaina M. Gartner
Employment - Seagen
Stock and Other Ownership Interests - Seagen
Research Funding - Agensys (Inst); Astellas Pharma (Inst); Seagen (Inst)
Travel, Accommodations, Expenses - Seagen
 
Rong Chu
Employment - Agensys
Stock and Other Ownership Interests - Vertex
 
Banmeet Anand
Employment - Agensys
Stock and Other Ownership Interests - Agensys
 
Fernando Doñate
Employment - Agensys
Patents, Royalties, Other Intellectual Property - Agensys; Attenuon
 
Lynnae Jackson
Employment - Agensys
 
Jeffrey Adams
Employment - Agensys; Puma Biotechnology (I)
Stock and Other Ownership Interests - Puma Biotechnology (I)
 
Amal Melhem-Bertrandt
Employment - Astellas Pharma
 
Jonathan E. Rosenberg
Stock and Other Ownership Interests - Illumina; Merck
Honoraria - AstraZeneca; Bristol-Myers Squibb; UpToDate
Consulting or Advisory Role - Agensys; AstraZeneca/MedImmune; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; EMD Serono; Lilly; Merck; Oncogenex; Roche/Genentech; Sanofi; Seagen
Research Funding - Agensys (Inst); Genentech (Inst); Genentech/Roche (Inst); Mirati Therapeutics (Inst); Novartis (Inst); Oncogenex (Inst); Viralytics (Inst)
Patents, Royalties, Other Intellectual Property - ERCC2 predicting cisplatin sensitivity
Travel, Accommodations, Expenses - Genentech/Roche